Pfizer Inc. (PFE) CEO Albert Bourla on Q2 2019 Results - Earnings Call Transcript

Jul. 29, 2019 4:35 PM ETPfizer Inc. (PFE)
SA Transcripts profile picture
SA Transcripts

Pfizer Inc. (NYSE:PFE) Q2 2019 Earnings Conference Call July 29, 2019 10:30 AM ET

Company Participants

Chuck Triano - Senior Vice President, Investor Relations

Albert Bourla - Chief Executive Officer

Frank D'Amelio - Chief Financial Officer

Angela Hwang - Group President, Biopharmaceuticals Group

Mikael Dolsten - President, Worldwide Research and Development

Doug Lankler - General Counsel

Conference Call Participants

Steve Scala – Cowen

Tim Anderson - Wolfe Research.

Terence Flynn - Goldman Sachs.

Umer Raffat - Evercore ISI

Chris Schott - JPMorgan

Andrew Baum - Citi

Jason Gerberry - Jason Gerberry

Louise Chen - Cantor

David Risinger - Morgan Stanley

David Maris - Wells Fargo

Mani Foroohar - SBC Leerink

Navin Jacob - UBS


Good day everyone and welcome to Pfizer's Second Quarter 2019 Earnings Conference Call. Today's call is being recorded.

At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Please go ahead sir.

Chuck Triano

Good morning and thank you for joining us today to review Pfizer's second quarter 2019 performance and our updated 2019 financial guidance. We appreciate your flexibility today. I know it's been a busy morning for everyone.

I'm joined today by our CEO, Albert Bourla; Frank D'Amelio, our CFO; Mikael Dolsten, President of Worldwide Research and Development; Angela Hwang, Group President Pfizer Biopharmaceuticals Group; John Young, our Chief Business Officer; and Doug Lankler, our General Counsel.

The slides that will be presented on this call were posted to our website earlier this morning and are available at You'll see here that Slide 3 covers our legal disclosures. Also any discussion related to our recently announced proposed transaction with Mylan to combine Upjohn and Mylan to create a new global pharmaceutical company is subject to certain risks and uncertainties that are discussed under

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.